Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
NCT02316886
Arterial Occlusive Diseases, Arteriosclerosis
New York, United States
View Trial DetailsNCT Number: NCT01559493
Comparison of Fractional Flow Reserve versus instant Wave-Free Ratio for assessment of coronary artery stenosis severity in routine practice
* To compare FFR to iFR in arbitrary consecutive patients referred for percutaneous coronary intervention (PCI). * To investigate the influence of hyperemia on iFR. * To test reproducibility of iFR and FFR.
Looking for future studies?
Notify MeAll sexes
Observational
Cardiovascular Center Aalst, Aalst, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days
In this prospective, multicenter, international investigation, all consecutive patients in 5 centers, referred for PCI will be included. FFR will be submitted for one vessel in each patient - this will be the first vessel in which the FFR is performed. Measurements will be performed in duplicate. iFR will be calculated for all lesions for which an FFR measurement is submitted. In addition, iFR and FFR will be compared retrospectively in 1000 patients who had FFR measurements in the recent past
Time frame: 30 days
iFR is said to be independent of hyperemia. Accordingly a secondary outcome of this study will be a paired comparison of iFR at rest vs iFr with adenosine induced hyperemia.
Time frame: 30 days
To test repeatability of iFR and FFR
NHS National Waiting Times Centre Board
Other
Comparison of Fractional Flow Reserve Versus Instant Wave-Free Ratio for Assessment of Coronary Artery Stenosis Severity in Routine Practice
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02316886
Arterial Occlusive Diseases, Arteriosclerosis
New York, United States
View Trial DetailsNCT06025305
Arterial Occlusive Diseases, Arteriosclerosis
Nanjing, Jiangsu, China
View Trial DetailsNCT06305559
Arterial Occlusive Diseases, Arteriosclerosis
Hialeah, Florida, United States
View Trial DetailsNCT06767345
Arterial Occlusive Diseases, Arteriosclerosis
Seoul, South Korea
View Trial Details